Literature DB >> 18030516

Ischemia heart disease and greater waist circumference are risk factors of renal function deterioration in male gout patients.

Ben Yu-Jih Su1, Han-Ming Lai, Chung-Jen Chen, Ying-Chou Chen, Chun-Kai Chiu, Ko-Ming Lin, Shan-Fu Yu, Tien-Tsai Cheng.   

Abstract

We examined the incidence of renal function deterioration (RFD) in a population of male gout patients and to identify associated risk factors. Subjects who had been regularly followed up for more than 2 years and had visited Chang Gung Memorial Hospital-Kaohsiung Medical Center Rheumatology Clinic between June 1, 2006 and January 31, 2007 were enrolled. Four subjects were excluded as secondary gout was suspected. Group I (Gr I) comprised subjects without RFD and group II (Gr II) comprised subjects with RFD during the follow-up period. RFD was defined as absolute increment in creatinine (Cr) levels over 0.4 mg/dl for subjects with baseline Cr levels <or=1.4 mg/dl or as more than 50% increment of baseline Cr level per 12-month interval in average for subjects with baseline Cr levels >1.4 mg/dl. Clinical parameters were analyzed to study the potential risk factors of RFD. Of 318 male gout patients, 296 (93.1%) were categorized as Gr I, and 22 (6.9%) were categorized as Gr II. The observation periods for Gr I and Gr II were 81.20+/-53.29 and 92.41+/-46.72 months, respectively (p=0.338). Initial Cr levels are similar between the two groups (1.25+/-0.51 vs 1.25+/-0.61, p=0.963). Multiple logistic regression analysis revealed that current age, age at disease onset, disease duration, treatment duration, body weight, height, family history of gout, tophi, urolithiasis, tobacco use, alcohol consumption, history of cerebral vascular accident, hypertension, diabetes mellitus, dyslipidemia, base-line and final Cr, blood urea nitrogen level, serum uric acid level, and body-mass index were not independent risk factors. However, history of ischemic heart disease [IHD; odds ratio (OR) 7.68, 95% confidence interval (CI) 1.99-29.70] and greater waist circumference (WC; OR 1.06, 95% CI 1.01-1.11) were two independent risk factors of RFD. Additionally, the Cox multivariable analysis disclosed that IHD (p<0.001) and greater WC (p=0.011) deteriorated kidney function in these patients. The incidence of RFD in male gout patients is 6.9%. History of IHD and greater WC are two independent risk factors for developing RFD.

Entities:  

Mesh:

Year:  2007        PMID: 18030516     DOI: 10.1007/s10067-007-0750-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  35 in total

Review 1.  Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?

Authors:  Joshua F Baker; Eswar Krishnan; Lan Chen; H Ralph Schumacher
Journal:  Am J Med       Date:  2005-08       Impact factor: 4.965

2.  Renal disease in primary gout: a study of 253 gout patients with proteinuria.

Authors:  T F Yü; L Berger
Journal:  Semin Arthritis Rheum       Date:  1975-05       Impact factor: 5.532

3.  Renal outcomes of gout and hyperuricemia.

Authors:  W J Fessel
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

4.  Correlates and consequences of asymptomatic hyperuricemia.

Authors:  W J Fessel; A B Siegelaub; E S Johnson
Journal:  Arch Intern Med       Date:  1973-07

5.  Renal disease in primary gout.

Authors:  K A Barlow; L J Beilin
Journal:  Q J Med       Date:  1968-01

Review 6.  Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.

Authors:  Gary L Myers; W Greg Miller; Josef Coresh; James Fleming; Neil Greenberg; Tom Greene; Thomas Hostetter; Andrew S Levey; Mauro Panteghini; Michael Welch; John H Eckfeldt
Journal:  Clin Chem       Date:  2005-12-06       Impact factor: 8.327

Review 7.  Obesity and renal hemodynamics.

Authors:  R J Bosma; J A Krikken; J J Homan van der Heide; P E de Jong; G J Navis
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580

8.  Body mass index and the risk of chronic renal failure: the Asian experience.

Authors:  Kunitoshi Iseki
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580

Review 9.  Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?

Authors:  Robert W Schrier
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

10.  Renal function in gout. V. Factors influencing the renal hemodynamics.

Authors:  T F Yü; L Berger; D J Dorph; H Smith
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

View more
  3 in total

1.  The combined use of edaravone, diuretics, and nonsteroidal anti-inflammatory drugs caused acute kidney injury in an elderly patient with chronic kidney disease.

Authors:  Guang Jian Liu; Yun Fu Wang; Yan Jun Zeng; Li Ding; Guo Jun Luo; Li Ping Zhang; Jian'e Zhang
Journal:  CEN Case Rep       Date:  2012-06-08

Review 2.  Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  Maud Wieczorek; James Martin Gwinnutt; Maxime Ransay-Colle; Suzanne Mm Verstappen; Francis Guillemin; Andra Balanescu; Heike Bischoff-Ferrari; Annelies Boonen; Giulio Cavalli; Savia de Souza; Annette de Thurah; Thomas Ernst Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja A Stamm; Karen Walker-Bone; Joep Welling; Mirjana Zlatkovic-Svenda
Journal:  RMD Open       Date:  2022-03

Review 3.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Giulio Cavalli; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana I Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.